Language: English
Published by Basel, Birkhäuser, 2005
Seller: Antiquariat Thomas Haker GmbH & Co. KG, Berlin, Germany
Association Member: GIAQ
Hardcover/Pappeinband. Condition: Sehr gut. 252 p. Very good. Shrink wrapped. / Sehr guter Zustand. In Folie verschweißt. Sprache: Englisch Gewicht in Gramm: 753.
Condition: New. pp. 260 Illus.
Condition: New. pp. 260.
Condition: New. pp. 260.
Seller: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Seller: Basi6 International, Irving, TX, U.S.A.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Seller: BennettBooksLtd, Los Angeles, CA, U.S.A.
Hardcover. Condition: New. In shrink wrap. Looks like an interesting title!
Seller: BennettBooksLtd, Los Angeles, CA, U.S.A.
Hardcover. Condition: New. In shrink wrap. Looks like an interesting title!
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 136.79
Quantity: Over 20 available
Add to basketCondition: New. In.
Condition: New. It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. This book discusses Molecular biology, clinics and therapy. Editor(s): Zipfel, Peter F. Series: Progress in Inflammation Research. Num Pages: 252 pages, biography. BIC Classification: MFG; MJCM; MJR; MMFM; PSF. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 16. Weight in Grams: 603. . 2005. 2006th Edition. hardcover. . . . .
Language: English
Published by Birkhäuser Basel, Birkhäuser Basel, 2005
ISBN 10: 3764371668 ISBN 13: 9783764371661
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. A large panel of distinct human kidney diseases is caused by defective complement control. Genetic analyses have identified mutations in complement regulators that are associated with these diseases. Mutations have been identified in the fluid phase alternative pathway regulator Factor H and the membrane regulator Membrane Cofactor Protein MCP (CD46). The functional characterization of the mutant proteins allows to define the pathophysiological events on a molecular level. These new concepts and data on disease mechanisms allowed establishing new diagnostic and promising therapeutic approaches for several human kidney diseases. Molecular biology, clinics and therapy are discussed in this volume.
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 1st edition. 236 pages. 9.00x6.50x0.75 inches. In Stock.
Condition: New. It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. This book discusses Molecular biology, clinics and therapy. Editor(s): Zipfel, Peter F. Series: Progress in Inflammation Research. Num Pages: 252 pages, biography. BIC Classification: MFG; MJCM; MJR; MMFM; PSF. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 16. Weight in Grams: 603. . 2005. 2006th Edition. hardcover. . . . . Books ship from the US and Ireland.
Seller: Mispah books, Redhill, SURRE, United Kingdom
Hardcover. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Language: English
Published by Springer, Basel, Birkhäuser Basel, Birkhäuser Dez 2005, 2005
ISBN 10: 3764371668 ISBN 13: 9783764371661
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. A large panel of distinct human kidney diseases is caused by defective complement control. Genetic analyses have identified mutations in complement regulators that are associated with these diseases. Mutations have been identified in the fluid phase alternative pathway regulator Factor H and the membrane regulator Membrane Cofactor Protein MCP (CD46). The functional characterization of the mutant proteins allows to define the pathophysiological events on a molecular level. These new concepts and data on disease mechanisms allowed establishing new diagnostic and promising therapeutic approaches for several human kidney diseases. Molecular biology, clinics and therapy are discussed in this volume. 236 pp. Englisch.
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Role of genetic mutations in regulator proteinsNew therapies in human kidney diseasesProf. Zipfel is a well renowned scientist in this area of researchThe understanding how complement relates to glomerular diseaseshas evolved con.
Seller: preigu, Osnabrück, Germany
Buch. Condition: Neu. Complement and Kidney Disease | Peter F Zipfel | Buch | Progress in Inflammation Research | xvi | Englisch | 2005 | Birkhäuser | EAN 9783764371661 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Language: English
Published by Birkhäuser, Birkhäuser Dez 2005, 2005
ISBN 10: 3764371668 ISBN 13: 9783764371661
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Buch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. A large panel of distinct human kidney diseases is caused by defective complement control. Genetic analyses have identified mutations in complement regulators that are associated with these diseases. Mutations have been identified in the fluid phase alternative pathway regulator Factor H and the membrane regulator Membrane Cofactor Protein MCP (CD46). The functional characterization of the mutant proteins allows to define the pathophysiological events on a molecular level. These new concepts and data on disease mechanisms allowed establishing new diagnostic and promising therapeutic approaches for several human kidney diseases. Molecular biology, clinics and therapy are discussed in this volume.Springer Nature c/o IBS, Benzstrasse 21, 48619 Heek 260 pp. Englisch.